Letter to the editor re: Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment-Reference-Cited by-同舟云学术

Letter to the editor re: Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment

Published:2018-08-31 Issue:6 Volume:23 Page:240-240
ISSN:2515-446X
Container-title:BMJ Evidence-Based Medicine
language:en
Short-container-title:BMJ EBM

Author:

Koretz Ronald L,Jakobsen Janus Christian,Gluud Christian

Publisher

BMJ

Subject

General Medicine

Reference5 articles.

1. Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment;Dobler;BMJ Evid Based Med,2018

2. Is widespread screening for hepatitis C justified?

3. American Association for the Study of Liver Diseases and the Infectious Diseases Society of America. HCV guidance: recommendations for testing, managing, and treating hepatitis C. Updated 24 May 2018. www.hcvguideolines.org (accessed 15 Jun 2018).

4. Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon

5. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C;Koretz;Cochrane Database Syst Rev,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decision-making given surrogate outcomes;Journal of Clinical Epidemiology;2022-05

2. Evidence-making interventions in health: A conceptual framing;Social Science & Medicine;2019-10

3. Evidence-making hepatitis C cure: Towards a science that knows more carefully;International Journal of Drug Policy;2019-10